Acer Therapeutics
Stock Forecast, Prediction & Price Target
Acer Therapeutics Financial Estimates
Acer Therapeutics Revenue Estimates
Acer Therapeutics EBITDA Estimates
Acer Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2020 | 12/31/2021 | 12/31/2022 | 12/31/2025 | |||
Revenue
% change YoY
| $0 N/A | $1.26M 0% | $0 -100% | Avg: $109.94M Low: $67.19M High: $152.70M avg. 0% | |||
Net Income
% change YoY
| $-22.89M N/A | $-14.72M 35.67% | $-27.86M -89.15% | Avg: $27.89M Low: $11.82M High: $11.82M avg. 200.11% | |||
EBITDA
% change YoY
| $-22.73M N/A | $-16.00M 29.60% | $-24.81M -55.04% | Avg: $21.98M Low: $13.43M High: $30.54M avg. 188.61% | |||
EPS
% change YoY
| -$2.06 N/A | -$1.03 50% | -$1.77 -71.84% | Avg: $0.75 Low: $0.75 High: $0.75 avg. 142.37% | |||
Operating Expenses
% change YoY
| $22.80M N/A | $17.20M -24.53% | $24.61M 43.03% | Avg: $0 Low: $0 High: $0 avg. -100% | |||
FAQ
What is Acer Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 200.11% in 2025-2025.
We have gathered data from 1 analysts. Their low estimate is 11.82M, average is 27.89M and high is 11.82M.
What is Acer Therapeutics stock revenue growth forecast?
We have gathered data from 1 analysts. Their low revenue estimate is $67.19M, average is $109.94M and high is $152.70M.
What is Acer Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 142.37% in 2025-2025.
We have gathered data from 1 analysts. Their low earnings per share estimate is $0.75, average is $0.75 and high is $0.75.